• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二十四章:过敏反应。

Chapter 24: Anaphylaxis.

出版信息

Allergy Asthma Proc. 2012 May-Jun;33 Suppl 1:80-83. doi: 10.2500/aap.2012.33.3557.

DOI:10.2500/aap.2012.33.3557
PMID:22794697
Abstract

Anaphylaxis is a sudden-onset, immediate reaction that implies a risk of death. Think of a "rule of 2's" for anaphylaxis implying that reactions usually begin within 2 minutes to 2 hours after injection, infusion, ingestion, contact, or inhalation. Fatalities can be from asphyxiation from laryngeal or oropharyngeal swelling, collapse from hypotensive shock, cardiac arrest, or acute severe bronchoconstriction causing respiratory failure and arrest. When there is activation of mast cells and basophils in anaphylaxis, chemical mediators are detectable. The preformed mediators from mast cells include histamine, tryptase, carboxypeptidase A, and proteoglycans (heparin and chondroitin sulfates). Newly synthesized mediators include prostaglandin D(2), leukotriene D(4), and platelet-activating factor. Crucial actions of the mediators include an abrupt increase in vascular permeability, vascular smooth muscle relaxation, and bronchial smooth muscle contraction. Anaphylaxis can be classified into immunologic, nonimmunologic, or idiopathic based on the associated mechanism. For example, immunologic causes of anaphylaxis are those mediated by IgE antibodies acting through the FcεR I (foods, insect venom, and beta-lactam antibiotics) whereas non-IgE immunologic anaphylaxis is mediated without presence of antiallergen IgE antibodies or via FcεRI activation (radiographic contrast material). Nonimmunologic anaphylaxis involves mast cell mediator release such as occurs with exercise, cold temperature exposure, or from medications such as opioids or vancomycin. Idiopathic anaphylaxis involves mast cell activation (acutely elevated urine histamine or serum tryptase) and activated lymphocytes. Because anaphylaxis is a medical emergency, the drug of choice is epinephrine, not H(1)-receptor antagonists.

摘要

过敏反应是一种突然发作的即刻反应,意味着有死亡的风险。对于过敏反应,可以考虑“2 规则”,即反应通常在注射、输注、摄入、接触或吸入后 2 分钟至 2 小时内开始。死亡可能是由于喉头或口咽肿胀导致窒息、低血压性休克引起的衰竭、心脏骤停或急性严重支气管痉挛导致呼吸衰竭和骤停。当过敏反应中肥大细胞和嗜碱性粒细胞被激活时,可检测到化学介质。肥大细胞预先形成的介质包括组胺、类胰蛋白酶、羧肽酶 A 和糖蛋白(肝素和硫酸软骨素)。新合成的介质包括前列腺素 D(2)、白三烯 D(4)和血小板激活因子。介质的关键作用包括血管通透性突然增加、血管平滑肌松弛和支气管平滑肌收缩。根据相关机制,过敏反应可分为免疫性、非免疫性或特发性。例如,过敏反应的免疫原因是 IgE 抗体通过 FcεR I(食物、昆虫毒液和β-内酰胺类抗生素)介导,而非 IgE 免疫性过敏反应是在没有抗过敏原 IgE 抗体存在的情况下通过 FcεRI 激活(造影剂)介导的。非免疫性过敏反应涉及肥大细胞介质释放,如运动、暴露于寒冷温度或药物(如阿片类药物或万古霉素)引起的释放。特发性过敏反应涉及肥大细胞激活(尿组胺或血清类胰蛋白酶水平急性升高)和活化的淋巴细胞。由于过敏反应是一种医疗紧急情况,因此首选药物是肾上腺素,而不是 H(1)-受体拮抗剂。

相似文献

1
Chapter 24: Anaphylaxis.第二十四章:过敏反应。
Allergy Asthma Proc. 2012 May-Jun;33 Suppl 1:80-83. doi: 10.2500/aap.2012.33.3557.
2
Anaphylaxis.过敏反应。
Allergy Asthma Proc. 2019 Nov 1;40(6):453-456. doi: 10.2500/aap.2019.40.4270.
3
Mechanisms Governing Anaphylaxis: Inflammatory Cells, Mediators, Endothelial Gap Junctions and Beyond.过敏反应的发生机制:炎症细胞、介质、内皮细胞缝隙连接及其他。
Int J Mol Sci. 2021 Jul 21;22(15):7785. doi: 10.3390/ijms22157785.
4
Anaphylaxis and Anaphylactoid Reactions: Diagnosis and Management.过敏反应和类过敏反应:诊断与管理
Am J Ther. 1996 Jul;3(7):515-520. doi: 10.1097/00045391-199607000-00007.
5
Anaphylaxis is a rare reaction in COVID-19 vaccination.在 COVID-19 疫苗接种中,过敏反应较为罕见。
J Biol Regul Homeost Agents. 2021 May-Jun;35(3):839-842. doi: 10.23812/BELLOMO_EDIT_3_21.
6
Mechanisms of Anaphylaxis Beyond IgE.超越IgE的过敏反应机制。
J Investig Allergol Clin Immunol. 2016;26(2):73-82; quiz 2p following 83. doi: 10.18176/jiaci.0046.
7
Patterns of anaphylaxis: acute and late phase features of allergic reactions.过敏反应模式:过敏反应的急性期和晚期特征
Novartis Found Symp. 2004;257:101-10; discussion 110-5, 157-60, 276-85.
8
Bugged.有故障的;有缺陷的
Emerg Med Serv. 2003 May;32(5):48.
9
[Severe allergic-immunologic reactions].[严重过敏免疫反应]
Praxis (Bern 1994). 1997 Feb 18;86(8):314-8.
10
9. Anaphylaxis.9. 过敏反应。
J Allergy Clin Immunol. 2008 Feb;121(2 Suppl):S402-7; quiz S420. doi: 10.1016/j.jaci.2007.08.061.

引用本文的文献

1
Proteomic and Biological Analysis of an Human Endothelial System in Response to Drug Anaphylaxis.药物过敏反应中人类内皮系统的蛋白质组学和生物学分析。
Front Immunol. 2021 Jun 25;12:692569. doi: 10.3389/fimmu.2021.692569. eCollection 2021.
2
Clinical Manifestations and Causes of Anaphylaxis. Analysis of 382 Cases from the Anaphylaxis Registry in West Pomerania Province in Poland.过敏反应的临床表现和病因。波兰西波美拉尼亚省过敏登记处 382 例分析。
Int J Environ Res Public Health. 2020 Apr 17;17(8):2787. doi: 10.3390/ijerph17082787.
3
Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis.
药物性过敏反应的流行病学、机制与诊断
Front Immunol. 2017 May 29;8:614. doi: 10.3389/fimmu.2017.00614. eCollection 2017.
4
Anaphylaxis Conundrum: A Trojan Horse Phenomenon.过敏反应难题:一种特洛伊木马现象。
J Allergy Clin Immunol Pract. 2017 Mar-Apr;5(2):325-329. doi: 10.1016/j.jaip.2016.08.008. Epub 2016 Oct 17.
5
Anaphylaxis Imaging: Non-Invasive Measurement of Surface Body Temperature and Physical Activity in Small Animals.过敏反应成像:小动物体表体温和身体活动的非侵入性测量
PLoS One. 2016 Mar 10;11(3):e0150819. doi: 10.1371/journal.pone.0150819. eCollection 2016.
6
IgE-based Immunotherapy of Cancer -A Comparative Oncology Approach.基于IgE的癌症免疫疗法——一种比较肿瘤学方法。
J Carcinog Mutagen. 2014 May 31;5(3):1000176. doi: 10.4172/2157-2518.1000176.
7
Prospects for therapeutic tolerance in humans.人类治疗性耐受的前景。
Curr Opin Rheumatol. 2014 Mar;26(2):219-27. doi: 10.1097/BOR.0000000000000029.
8
MRI reveals edema in larynx (but not in brain) during anaphylactic hypotension in anesthetized rats.MRI 显示在麻醉大鼠过敏引起的低血压期间喉(而非脑)水肿。
Allergy Asthma Immunol Res. 2013 Nov;5(6):389-96. doi: 10.4168/aair.2013.5.6.389. Epub 2013 Sep 2.
9
Chapter 17: Immunomodulation of allergic sinonasal disease.第十七章:变应性鼻-鼻窦炎的免疫调节。
Am J Rhinol Allergy. 2013 May-Jun;27 Suppl 1(3 Suppl):S59-62. doi: 10.2500/ajra.2013.27.3930.
10
Chapter 16: Determining the role of allergy in sinonasal disease.第十六章:确定过敏在鼻-鼻窦疾病中的作用。
Am J Rhinol Allergy. 2013 May-Jun;27 Suppl 1(3 Suppl):S56-8. doi: 10.2500/ajra.2013.27.3929.